Genetics: Hereditary breast and ovarian cancers - JAAPA
Links shared publicly online about this topic.
- 2,101total visits
Genetics: Hereditary breast and ovarian cancers - JAAPA
View full resource at jaapa.com
Tags: Genetic, Cancer, Ovarian Cancer, Women's Health, Surgery
Most Recently Shared on April 20, 2009 at 7:27 pm By:
Women testing + for BRCA1/BRCA2 mutations have 3 options: surveillance, chemoprevention, or prophylactic surgery http://tinyurl.com/dmhhwo
Genetic Assessment of Breast and Ovarian Cancer Risk
onclive.com — “Understanding the genetic basis of breast and ovarian cancers is essential to providing patients with effective preventive and/or management strategies that can improve outcomes.” View full resource at onclive.com
Most Recently Shared on April 30, 2012 at 9:54 pm By:
Genetic Assessment of Breast and Ovarian Cancer Risk http://t.co/4kMgyjhk
Should Parents Disclose A Genetic Predisposition To Breast Cancer To Their Children?
medicalnewstoday.com — “When a mother undergoes genetic testing to determine whether she carries a gene for hereditary breast cancer, the parents must then decide whether and how to share this risk information with their” View full resource at medicalnewstoday.com
Most Recently Shared on April 3, 2012 at 8:05 am By:
MNT Pediatrics News Pediatrics and Health News
Should Parents Disclose A Genetic Predisposition To Breast Cancer To Their Children? http://t.co/oDVbHEn8 #pediatrics
Supreme Court Orders New Look at Gene Patents - NYTimes.com
nytimes.com — “Appellate judges were told to reconsider a ruling that let Myriad Genetics patent two genes associated with a high risk of breast and ovarian cancer.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 12:41 pm By:
Kent Bottles, MD Doctor, Pathologist, and Physician
Supreme Court Orders New Look at Gene Patents: http://t.co/qmY75BSZ
Supreme Court Orders New Look at Gene Patents - NYTimes.com
nytimes.com — “Appellate judges were told to reconsider a ruling that let Myriad Genetics patent two genes associated with a high risk of breast and ovarian cancer.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 6:30 am By:
Richard Hom OD MPA Active Health Library, Doctor, and Optometrist
Supreme Court Orders New Look at Gene Patents - Appellate judges were told to reconsider a ruling that let Myriad Ge... http://t.co/27Y6qEZy
Myriad gene patent ruling sent back to lower court | Reuters
reuters.com — “WASHINGTON (Reuters) - The U.S. Supreme Court on Monday set aside a ruling that said Myriad Genetics Inc could patent two genes linked to breast and ovarian cancers, and ordered further review by a lower” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 8:18 pm By:
Myriad gene patent ruling sent back to lower court http://t.co/vjfDYoZa
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library
www3.interscience.wiley.com — “Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at www3.interscience.wiley.com
Most Recently Shared on March 26, 2012 at 7:00 am By:
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics: (Source: Journal of ... http://t.co/NZgs3x4A
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library
onlinelibrary.wiley.com — “Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 26, 2012 at 6:26 am By:
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics: (Source: Journal of ... http://t.co/No2XOoDC
Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers - Barnes - 2012 - Journal of Internal Medicine - Wiley Online Library
onlinelibrary.wiley.com — “Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers - Barnes - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 25, 2012 at 11:23 am By:
Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic... http://t.co/DyjNCRLu
DNA marker predicts platinum drug response in breast, ovarian cancer - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber and Brigham and Women’s researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at dana-farber.org
Most Recently Shared on March 24, 2012 at 10:30 pm By:
Discovery of genetic marker predicting response to platinum drugs in triple-negative #breastcancer http://t.co/IFMrAlTO
Predicting platinum drug response in breast, ovarian cancers - National Cancer Institute
cancer.gov — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-base” View full resource at cancer.gov
Most Recently Shared on March 23, 2012 at 9:20 pm By:
Researchers at @DanaFarber find DNA marker predicts platinum drug response in #breast, #ovarian #cancer http://t.co/whanFNVZ
Genetic marker identifies tumors unable to repair DNA damage by platinum agents
news-medical.net — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 2:58 pm By:
Genetic marker identifies tumors unable to repair DNA damage by platinum agents: Scientists from Brigham and Wom... http://t.co/hCvtHq12
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 4:29 pm By:
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer: Brigham and Women's Hospital and Dana-Farb... http://t.co/6ciU9u4w
DNA marker predicts platinum drug response in breast, ovarian cancer
medicalxpress.com — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive 'triple negative' breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 2:45 pm By:
PhysOrg Health News Health News
DNA marker predicts platinum drug response in breast, ovarian cancer http://t.co/3Uu90Gwq
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:39 pm By:
newswise Health Communicator and Health News
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/Yf75k9xK
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:31 pm By:
#health news: DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/lGmyGKPG
Advertisement
